People · Operator
Named in public records as an officer, director or promoter · active 2016–2022 · Healthtech, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Monteris Medical US, Inc. | — | Healthtech | Series B | $82.5M | $168.2M | 2016 |
| Contraline, Inc. | — | Biotechnology | Series A | $7.2M | $189.4M | 2021 |
Martin Emerson at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Martin Emerson on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Kirk Nielsen | 1 | 13 |
| Michael King | 1 | 6 |
| Patrick Morand | 1 | 5 |
| John Schellhorn | 1 | 4 |
| Gregory Barrett | 1 | 4 |
| James Richardson | 1 | 4 |
| Joe Biller | 1 | 3 |
| Joseph Biller | 1 | 3 |
| Richard Emmitt | 1 | 3 |
| Matthew Strobeck | 1 | 3 |
| James Reinstein | 1 | 3 |
| Daniel Cole | 1 | 2 |
| Kevin McGarry | 1 | 2 |
| Gary Bantle | 1 | 2 |
| Robert K Davidson | 1 | 2 |
| James Erickson | 1 | 2 |
| Gurdane Bhutani | 1 | 2 |
| Kevin Eisenfrats | 1 | 1 |
| Tom Thorpe | 1 | 1 |
| Bill Hoffman | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.